精液等离子体PGK2作为一个预测生物标志物用于静脉瘤切除术后的精子运动性改善静脉瘤受试者
Cheng Yang1,2, Jianxiong Li1,3, Shenghao Wu1
1Department of Urology, The Third Affiliated Hospital, Southern Medical University, Guangzhou, China.
Translational andrology and urology
|March 21, 2025
概括
精液中糖酸酶2 (PGK2) 水平预测了经过静脉瘤切除术后精子运动的改善. 这种生物标志物有助于评估瘤相关的精子缩症治疗的有效性.
科学领域:
- 生殖生物学 生殖生物学
- 生物标志物发现发现
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
背景情况:
- 静脉切除术 (VC) 并不能保证所有患者的精液质量得到改善.
- 确定预测性生物标志物用于术后增强精子运动性至关重要.
研究的目的:
- 在精液等离子体中研究糖酸激酶2 (PGK2) 作为精子静脉切除术后精子运动的预测生物标志物.
- 评估静脉切除术在改善精液参数方面的疗效.
主要方法:
- 收集了来自60名静脉患者和33名健康捐赠者的精液和精液样本.
- 使用ELISA测量PGK2度,并分析了血液/精液参数.
- 采用机器学习算法来构建一个预测模型来预测瘤切除术的结果.
主要成果:
- 病毒冠状病毒患者的精液PGK2水平明显低于健康捐赠者 (P<0.001).
- 在静脉瘤切除术后,PGK2水平显著增加 (P<0.001).
- PGK2度独立预测了静脉瘤切除术的成功 (AUC=0.735) 和机器学习模型显示了高的分类准确性.
结论:
- 精子PGK2显示出作为生物标志物的潜力,可以预测经过静脉切除术后精子运动的改善.
- PGK2可以帮助临床医生做出明智的决定,了解瘤治疗策略.
相关概念视频
Infertility in Males
225
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
225
Spermatogenesis
102.0K
Spermatogenesis is the process by which haploid sperm cells are produced in the male testes. It starts with stem cells located close to the outer rim of seminiferous tubules. These spermatogonial stem cells divide asymmetrically to give rise to additional stem cells (meaning that these structures “self-renew”), as well as sperm progenitors, called spermatocytes. Importantly, this method of asymmetric mitotic division maintains a population of spermatogonial stem cells in the male...
102.0K


